Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorUniversity of Alberta
About this trial
Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications.
The investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
regularly experiencing pain, aching, or stiffness in and/or around the knee for at least 1 month
complete the screening PhIT-OA questionnaire
Disqualifiers
Prior total knee replacement or on the waitlist to have your knee replaced
Knee surgery within the previous 4 months
History of acute injury to knee within previous 6 months
Unable to speak and read English
Trial design
Design model
Single group
Treatments tested in this trial
Pharmacy-Physiotherapy Intervention
Other interventionPharmacists will provide comprehensive 1:1 patient care, including a complete patient assessment and medication review, provide specific drug therapy recommendation(s) using shared decision making (SDM), and provide patient education, including further written materials. Participants will be offered either individual or group physiotherapy sessions at the a private clinic.
Treatment groups
125 Participants
are divided into 2 treatment groupsGroup A: Usual Care (Control) GroupNo intervention 0 interventions
Group B: Intervention GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Disease specific self-report measure for OA
The Knee Injury in OA Outcome Score (KOOS) from 0-100 where a higher score is a better outcome.
Time frame
Baseline, Post Intervention (3 & 6 month after baseline)Secondary outcomes
1
Patient Activation Measure (PAM)
Scale from 0-100 where a higher score is a better outcome.
Time frame
Baseline, Post Intervention (3 & 6 month after baseline)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov